Research

Energy balance

52.9% of Semaglutide users reached the 2.4 mg dose compared to 77.6% of Tirzepatide users reaching 15 mg.

Practitioners should note the higher success rate of Tirzepatide in reaching the maintenance dose.

StrongSupportsmedium confidence
Among 739 medication courses, 52.9% of Semaglutide users reached the 2.4 mg dose versus 77.6% of tirzepatide users reaching 15 mg (p < 0.001).
Goar Alvarez et al. · Obesities · 2025

Why this rating

Based on the retrospective observational study design with a substantial sample size.

Source

Evaluating Dose Titration in Semaglutide and Tirzepatide for Weight Loss: A Retrospective Academic Call Center Study

Goar Alvarez et al. · Obesities · 2025

DOI 10.3390/obesities5040090

cohort · n=739
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →